MRP ₹37
(Inclusive of all Taxes)
₹4.4 Cashback (12%)
%2520JP_OneCard.png?tr=q-85,f-webp,w-50,dpr-1,c-at_max){kind=small}
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
Expires on or after :
Have a query?
Drug-Drug Interactions
Drug-Drug Interactions
Login/Sign Up
Taking atazanavir with Rantac 50 mg Injection 5 x 2 ml can reduce the effectiveness of atazanavir.
How to manage the interaction:
Although taking Rantac 50 mg Injection 5 x 2 ml together with Atazanavir can possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor if you experience unusual symptoms. Do not discontinue any medicine without consulting a doctor.
Coadministration of Rilpivirine with Rantac 50 mg Injection 5 x 2 ml can reduce the acidity levels in the stomach and also decrease the effectiveness of Rilpivirine.
How to manage the interaction:
Although taking Rantac 50 mg Injection 5 x 2 ml together with Rilpivirine can possibly result in an interaction, they can be taken together if prescribed by your doctor. To reduce the chance of interaction, take Rantac 50 mg Injection 5 x 2 ml at least 12 hours before or 4 hours after taking rilpivirine. Do not discontinue any medicine without consulting a doctor.
Using Pazopanib with Rantac 50 mg Injection 5 x 2 ml can reduce the effectiveness of pazopanib
How to manage the interaction:
Although taking Rantac 50 mg Injection 5 x 2 ml together with Pazopanib can possibly result in an interaction, but can be taken together if prescribed by a doctor. However, if you experience any unusual symptoms contact your doctor immediately. Do not stop using any medications without first talking to your doctor.
Taking Rantac 50 mg Injection 5 x 2 ml and Dasatinib together reduces the effectiveness of Dasatinib.
How to manage the interaction:
Although taking Rantac 50 mg Injection 5 x 2 ml together with Dasatinib can result in an interaction, they can be taken together if prescribed by a doctor. However, contact a doctor if you experience any unusual symptoms. Do not discontinue any medicine without consulting a doctor.
Coadministration of loperamide with Rantac 50 mg Injection 5 x 2 ml may significantly increase the blood levels of loperamide. This can increase the risk of serious side effect like irregular heart rhythm.
How to manage the interaction:
Although taking loperamide with Rantac 50 mg Injection 5 x 2 ml together can result in an interaction, they can be taken if a doctor has prescribed it. However, if you experience sudden dizziness, lightheadedness, fainting, breathing difficulty, or rapid heartbeat, consult the doctor immediately. Do not stop using any medications without talking to a doctor.
Co-administration of Rantac 50 mg Injection 5 x 2 ml with Mesalazine can decrease the levels of Mesalazine, which may be less effective in treating a condition.
How to manage the interaction:
There may be a possible interaction between Mesalazine with Rantac 50 mg Injection 5 x 2 ml, but they can be taken together if a doctor has prescribed them. Do not discontinue any medications without consulting a doctor.
Coadministration of Gefitinib with Rantac 50 mg Injection 5 x 2 ml can reduce the acidity levels in the stomach and also decrease the effectiveness of gefitinib
How to manage the interaction:
Taking Gefitinib with Rantac 50 mg Injection 5 x 2 ml together can possibly result in an interaction, it can be taken if your doctor has advised it. It is recommended that gefitinib is either taken 6 hours before or 6 hours after Rantac 50 mg Injection 5 x 2 ml to help minimize the impact of the interaction. Do not stop using any medications without first talking to your doctor.
Taking these medications together might make it harder for your body to absorb atazanavir, which could make it less effective.
How to manage the interaction:
vv
Taking these medications together might make it harder for your body to absorb atazanavir, which could make it less effective.
How to manage the interaction:
v
Drug-Food Interactions
Drug-Food Interactions
Login/Sign Up
Alcohol
Caution
Drinking alcohol may cause dehydration and elevate the level of stomach acid. Hence, avoid consuming alcohol while on treatment with Rantac 50 mg Injection 5 x 2 ml.
Pregnancy
Caution
Rantac 50 mg Injection 5 x 2 ml is recommended in pregnancy only if clearly needed. So, inform your doctor if you are pregnant or suspect pregnancy. Your doctor will weigh the benefits and potential risks before prescribing Rantac 50 mg Injection 5 x 2 ml.
Breast Feeding
Caution
Rantac 50 mg Injection 5 x 2 ml is recommended in breastfeeding only if clearly needed. So, inform your doctor if you are a nursing mother. Your doctor will weigh the benefits and potential risks before prescribing Rantac 50 mg Injection 5 x 2 ml.
Driving
Safe if prescribed
Rantac 50 mg Injection 5 x 2 ml has no or negligible influence on the ability to drive and operate machines.
Liver
Caution
If you have a history or evidence of any liver disease, please inform the doctor before taking medicine. Your doctor may adjust the dose of these medicines based on your condition.
Kidney
Caution
If you have a history or evidence of any kidney diseases, please inform the doctor before taking the medicine. Your doctor may adjust the dose of these medicines based on your condition.
Children
Safe if prescribed
Rantac 50 mg Injection 5 x 2 ml is considered safe to be used in children. If you have any concerns, discuss them with the doctor.
Heart
Caution
Rantac 50 mg Injection 5 x 2 ml is generally safe for heart patients, but caution is advised as it may affect heart rhythm in rare cases. Always consult your doctor to ensure it's appropriate for your specific cardiac condition.
Geriatrics
Caution
Geriatric patients can generally receive Rantac 50 mg Injection 5 x 2 ml, but it may be more sensitive to side effects like confusion or changes in kidney function. It's important to have the dose adjusted and monitored by a healthcare provider based on individual health status.
Customers Also Bought
Disclaimer
Author Details
